Verdict94/ 100
Grade A · #1CoreAge Rx
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
Visit CoreAge RxHead-to-head verdict
CoreAge Rx vs Gala Health
Two GLP-1 providers, ruled side by side on The Verdict Score — our published six-factor rubric. Same yardstick, no pay-to-win placement.
vs
Verdict86/ 100
Grade B · #15Gala Health
One of the few names on the board that pairs a genuinely cheap compounded entry with a real brand-Ozempic path and nationwide coverage — the verdict docks it only for a sky-high brand sticker and an oral route it doesn't yet offer.
Visit Gala HealthThe verdict
Winner: CoreAge Rx
CoreAge Rx takes it with a higher Verdict Score — 94/100 to 86/100 (grade A vs B). Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch. Gala Health still earns its place — patients in any state who want to start on low-cost compounded tirzepatide but keep a legitimate brand-name option on the table.
Factor by factor
Both scored on the same six factors — see the methodology. The brass bar marks the stronger side on each.
92Real-world results85
92
Real-world results85
97Price honesty87
97
Price honesty87
96Prescriber access88
96
Prescriber access88
88Formulary choice88
88
Formulary choice88
95Cancellation fairness84
95
Cancellation fairness84
93Member support84
93
Member support84
Price, coverage & features
| Metric | CoreAge Rx | Gala Health |
|---|---|---|
| Verdict Score | 94/100 | 86/100 |
| Grade | A | B |
| Semaglutide | $149/mo | Not disclosed |
| Tirzepatide | $349/mo | $179/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | No | No |
CoreAge Rx
What we like
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation
The caveats
- Not the cheapest — flat-price challengers like Trimi Health and Alan Meds undercut its sticker price
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Gala Health
What we like
- Low compounded entry — tirzepatide at $179/mo, microdose at $149/mo, and a 3-month plan from $199/mo
- Available in all 50 states, so access never blocks the sign-up
- Offers a real FDA-approved brand path (Ozempic) alongside the compounded track — rare on this list
- Adjacent HRT and menopause care for patients who want more than a GLP-1 alone
The caveats
- GLP-1 is compounded, not FDA-approved — the standard verification caveat applies
- Brand Ozempic runs $1,299/mo — the brand path exists but is priced out of reach for most
- No oral or sublingual option yet
- Newer operator (AI Coaching Inc) with a thin public track record — vet the pharmacy yourself
Our pick — visit
Anyone who wants transparent flat pricing and nationwide access without a teaser-rate bait-and-switch.
Visit CoreAge Rx Read the full CoreAge Rx review →Also worth a look
Patients in any state who want to start on low-cost compounded tirzepatide but keep a legitimate brand-name option on the table.
Visit Gala Health Read the full Gala Health review →Keep comparing
Or browse the full comparison hub and the complete rankings.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.